UNRESECTABLE/METASTATIC ADRENOCORTICAL CARCINOMA

Clinical trials for UNRESECTABLE/METASTATIC ADRENOCORTICAL CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new UNRESECTABLE/METASTATIC ADRENOCORTICAL CARCINOMA trials appear

Sign up with your email to follow new studies for UNRESECTABLE/METASTATIC ADRENOCORTICAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Can a new drug shrink Hard-to-Treat adrenal tumors?

Disease control Not yet recruiting

This phase 2 trial is testing whether the drug ivonescimab can help control advanced or metastatic adrenal cancers, specifically adrenocortical carcinoma (ACC) and pheochromocytoma/paraganglioma (PPGL), that have not responded to prior treatment. About 20 adults with these rare c…

Matched conditions: UNRESECTABLE/METASTATIC ADRENOCORTICAL CARCINOMA

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Aug 05, 2026 00:00 UTC

UNRESECTABLE/METASTATIC ADRENOCORTICAL CARCINOMA

Get alerted when new UNRESECTABLE/METASTATIC ADRENOCORTICAL CARCINOMA trials appear

Can a new drug shrink Hard-to-Treat adrenal tumors?